R. Wachter 1, ⁎, S. Michele 2, K. Witte 3, E. Straburzynska-Migaj 4, J. Belohlavek 5, C. Fonseca 6, C. Mueller 7, E. Lonn 8, W. Bao 9, A. Noe 10, H. Schwende 10, D. Butylin 10, D. Pascual-Figal 11
on behalf of TRANSITION investigators
1 University of Göttingen, Clinic for cardiology and pneumologie, Basel, Switzerland
2 Cardiology Division, Cardiovascular Department Hospital Papa Giovanni XXIII, Italy
3 Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
4 1st Dept of Cardiology, University of Medical Sciences, Poznan, Poland
5 General Teaching Hospital, Charles University in Prague, Prague, Czech Republic
6 Heart Failure Unit, Internal Medicine Department, Hospital de São Francisco Xavier, CHLO. NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
7 University Hospital Basel, Basel, Switzerland
8 Hamilton Health Sciences General Site, Hamilton, Canada
9 Novartis Pharmaceuticals Corporation, East Hanover, USA
10 Novartis Pharma AG, Basel, Switzerland
11 Cardiology Department, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain